{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10954328", "DateCompleted": {"Year": "2000", "Month": "12", "Day": "22"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "26"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0031-6768", "JournalIssue": {"Volume": "440", "Issue": "3", "PubDate": {"Year": "2000", "Month": "Jul"}}, "Title": "Pflugers Archiv : European journal of physiology", "ISOAbbreviation": "Pflugers Arch"}, "ArticleTitle": "Hyperforin modulates gating of P-type Ca2+ current in cerebellar Purkinje neurons.", "Pagination": {"StartPage": "427", "EndPage": "434", "MedlinePgn": "427-34"}, "Abstract": {"AbstractText": ["Whole-cell, patch-clamp recordings from acutely isolated cerebellar Purkinje neurons demonstrate a two-stage modulation of P-type high-voltage-activated (HVA) Ca2+ current by a constituent of St. John's wort, hyperforin (0.04-0.8 microM). The first stage of modulation was voltage dependent and reversible. It comprised slow-down of the activation kinetics and a shift in the voltage dependence of P-current to more negative voltages. Hyperforin (0.8 microM) shifted the maximum of the current/voltage (I/V) relationship by -8+/-2 mV. The second, voltage-independent stage of modulation was manifested as a slowly developing inhibition of P-current that could not be reversed within the period of study. Neither form of modulation was abolished by intracellular guanosine 5'-O-(2-thiodiphosphate) (GDPPS) or guanosine 5'-O-(3-thiotriphosphate) (GTPgammaS) or by strong depolarising pre-pulses, indicating that modulation via guanine nucleotide-binding proteins (G proteins) is not involved in the observed phenomenon. Calmidazolium (0.5 microM), an antagonist of the intracellular Ca2+-binding protein calmodulin significantly inhibited the hyperforin-induced shift of the IIV curve maximum and the slow-down of the activation kinetics. It did not, however, affect the delayed inhibition of P-current, indicating that the two stages of modulation are mediated by separate mechanisms."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cellular Membranology, Bogomoletz Institute of Physiology, Kiev, Ukraine."}], "Identifier": [], "LastName": "Fisunov", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lozovaya", "ForeName": "N", "Initials": "N"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tsintsadze", "ForeName": "T", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chatterjee", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "N\u00f6ldner", "ForeName": "M", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Krishtal", "ForeName": "O", "Initials": "O"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Pflugers Arch", "NlmUniqueID": "0154720", "ISSNLinking": "0031-6768"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Bridged Bicyclo Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Calcium Channel Blockers"}, {"RegistryNumber": "0", "NameOfSubstance": "Calcium Channels, P-Type"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Thionucleotides"}, {"RegistryNumber": "0", "NameOfSubstance": "omega-Agatoxin IVA"}, {"RegistryNumber": "146-91-8", "NameOfSubstance": "Guanosine Diphosphate"}, {"RegistryNumber": "37589-80-3", "NameOfSubstance": "Guanosine 5'-O-(3-Thiotriphosphate)"}, {"RegistryNumber": "71376-97-1", "NameOfSubstance": "guanosine 5'-O-(2-thiodiphosphate)"}, {"RegistryNumber": "92078-76-7", "NameOfSubstance": "omega-Conotoxin GVIA"}, {"RegistryNumber": "DHD7FFG6YS", "NameOfSubstance": "Phloroglucinol"}, {"RegistryNumber": "RM741E34FP", "NameOfSubstance": "hyperforin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Bridged Bicyclo Compounds"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Calcium Channel Blockers"}, {"QualifierName": ["physiology"], "DescriptorName": "Calcium Channels, P-Type"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Guanosine 5'-O-(3-Thiotriphosphate)"}, {"QualifierName": ["analogs & derivatives", "pharmacology"], "DescriptorName": "Guanosine Diphosphate"}, {"QualifierName": [], "DescriptorName": "Hypericum"}, {"QualifierName": ["drug effects"], "DescriptorName": "Ion Channel Gating"}, {"QualifierName": ["drug effects"], "DescriptorName": "Membrane Potentials"}, {"QualifierName": [], "DescriptorName": "Patch-Clamp Techniques"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Phloroglucinol"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "physiology"], "DescriptorName": "Purkinje Cells"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["physiology"], "DescriptorName": "Second Messenger Systems"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Terpenes"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Thionucleotides"}, {"QualifierName": ["pharmacology"], "DescriptorName": "omega-Agatoxin IVA"}, {"QualifierName": ["pharmacology"], "DescriptorName": "omega-Conotoxin GVIA"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "8", "Day": "23", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "2", "Day": "28", "Hour": "10", "Minute": "1"}, {"Year": "2000", "Month": "8", "Day": "23", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10954328", "10.1007/s004240000306"]}}], "PubmedBookArticle": []}